Bio-equivalent tests to be mandatory.

The KFDA plans for the bio-equivalent test gradually to be mandatory in process of the drug health registration in order to activate the test. Furthermore, the KFDA intends to recommend an incentive plan to the MOHW for the drugs completed with the test including discriminated NHI reimbursement.

The incentive plans for the test provide many privileges to the items with which the tested drug ...